218 related articles for article (PubMed ID: 14661060)
21. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
22. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation.
Andoniou CE; Lill NL; Thien CB; Lupher ML; Ota S; Bowtell DD; Scaife RM; Langdon WY; Band H
Mol Cell Biol; 2000 Feb; 20(3):851-67. PubMed ID: 10629042
[TBL] [Abstract][Full Text] [Related]
23. The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system.
Rao N; Dodge I; Band H
J Leukoc Biol; 2002 May; 71(5):753-63. PubMed ID: 11994499
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Src family kinases blocks epidermal growth factor (EGF)-induced activation of Akt, phosphorylation of c-Cbl, and ubiquitination of the EGF receptor.
Kassenbrock CK; Hunter S; Garl P; Johnson GL; Anderson SM
J Biol Chem; 2002 Jul; 277(28):24967-75. PubMed ID: 11994282
[TBL] [Abstract][Full Text] [Related]
25. EGF receptor binding and transformation by v-cbl is ablated by the introduction of a loss-of-function mutation from the Caenorhabditis elegans sli-1 gene.
Thien CB; Langdon WY
Oncogene; 1997 May; 14(18):2239-49. PubMed ID: 9174060
[TBL] [Abstract][Full Text] [Related]
26. The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).
Kobayashi S; Sawano A; Nojima Y; Shibuya M; Maru Y
FASEB J; 2004 May; 18(7):929-31. PubMed ID: 15001553
[TBL] [Abstract][Full Text] [Related]
27. c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption.
Tanaka S; Amling M; Neff L; Peyman A; Uhlmann E; Levy JB; Baron R
Nature; 1996 Oct; 383(6600):528-31. PubMed ID: 8849724
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Cbl phosphorylation by the Abl tyrosine kinase and the Nck SH2/SH3 adaptor.
Miyoshi-Akiyama T; Aleman LM; Smith JM; Adler CE; Mayer BJ
Oncogene; 2001 Jul; 20(30):4058-69. PubMed ID: 11494134
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic forms of Cbl abrogate the anchorage requirement but not the growth factor requirement for proliferation.
Ojaniemi M; Langdon WY; Vuori K
Oncogene; 1998 Jun; 16(24):3159-67. PubMed ID: 9671395
[TBL] [Abstract][Full Text] [Related]
30. c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2.
Jacob C; Cottrell GS; Gehringer D; Schmidlin F; Grady EF; Bunnett NW
J Biol Chem; 2005 Apr; 280(16):16076-87. PubMed ID: 15708858
[TBL] [Abstract][Full Text] [Related]
31. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus.
Wilhelmsen K; Burkhalter S; van der Geer P
Oncogene; 2002 Feb; 21(7):1079-89. PubMed ID: 11850825
[TBL] [Abstract][Full Text] [Related]
32. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells.
Lupher ML; Reedquist KA; Miyake S; Langdon WY; Band H
J Biol Chem; 1996 Sep; 271(39):24063-8. PubMed ID: 8798643
[TBL] [Abstract][Full Text] [Related]
33. c-Cbl associates directly with the C-terminal tail of the receptor for the macrophage colony-stimulating factor, c-Fms, and down-modulates this receptor but not the viral oncogene v-Fms.
Mancini A; Koch A; Wilms R; Tamura T
J Biol Chem; 2002 Apr; 277(17):14635-40. PubMed ID: 11847211
[TBL] [Abstract][Full Text] [Related]
34. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
Andoniou CE; Thien CB; Langdon WY
Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
[TBL] [Abstract][Full Text] [Related]
35. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases.
Kowanetz K; Crosetto N; Haglund K; Schmidt MHH; Heldin CH; Dikic I
J Biol Chem; 2004 Jul; 279(31):32786-95. PubMed ID: 15159412
[TBL] [Abstract][Full Text] [Related]
36. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
37. A dominant negative Raf-1 mutant prevents v-Src-induced transformation.
Qureshi SA; Joseph CK; Hendrickson M; Song J; Gupta R; Bruder J; Rapp U; Foster DA
Biochem Biophys Res Commun; 1993 Apr; 192(2):969-75. PubMed ID: 7683468
[TBL] [Abstract][Full Text] [Related]
38. Distinct roles of p130Cas and c-Cbl in adhesion-induced or macrophage colony-stimulating factor-mediated signaling pathways in prefusion osteoclasts.
Nakamura I; Rodan GA; Duong LT
Endocrinology; 2003 Nov; 144(11):4739-41. PubMed ID: 12959979
[TBL] [Abstract][Full Text] [Related]
39. Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils.
Melander F; Andersson T; Dib K
Biochem J; 2003 Mar; 370(Pt 2):687-94. PubMed ID: 12435267
[TBL] [Abstract][Full Text] [Related]
40. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
Kassenbrock CK; Anderson SM
J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
